What happens when a Grammy-nominated artist enters biotech?
Aloe Blacc tells the Equity Podcast getting the initial idea isn’t the hard part. It’s regulators, clinical trials, and a system where celebrity doesn’t matter.
Catch the full convo here: http://spr.ly/6056B64e9e
